Clinical Trial

Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer

Study acronym: ESPY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, multi-centre, exploratory and observational one-arm study to evaluate preventive Endoluminal Vacuum Therapy(pEVT) to prevent anastomotic leakage after esophagectomy due to esophageal cancer. The main objective is to evaluate the potential protective effect of prophylactic preemptive endoluminal vacuum therapy on esophageal-gastric anastomosis dehiscence after esophagectomy.
Trial Details
NCT Number NCT06097078
Lead Sponsor Aesculap AG
Collaborators: B.Braun Surgical SA
Conditions Esophageal Cancer, Esophagus Cancer, Anastomotic Leak
Enrollment 44 participants
Start Date 2024-10-07
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-04